Sign In
Get Clay Free →

Suggestions

    Victor Dillard

    Venture Builder | Entrepreneur | Speaker __ VP, Strategy & Operations at Resolution Therapeutics

    Victor Dillard is a visionary professional dedicated to revolutionizing biotechnology through the integration of software and unlocking the potentials of genomics and personalized treatment.

    As the founder of Desktop Genetics in 2012, Victor spearheaded business development and CRISPR genome-editing efforts, positioning the company as a leader in CRISPR therapeutics research. His role as COO involved securing approximately $3M in business financing, expanding operations to accommodate a 20-person team, achieving a year-on-year sales increase, and overseeing $1M in R&D projects. Subsequently, as the CEO, he facilitated the company's acquisition by Celixir plc in June 2018.

    Victor's educational background includes an MEng in Chemical Engineering from Imperial College London and an MPhil in Bioscience Enterprise from the University of Cambridge. He has earned accolades such as Forbes 30 Under 30, MIT Innovator Under 35, and MIT Technology Review's Entrepreneur of the Year in 2017.

    Passionate about fostering entrepreneurship among graduates, PhDs, and postdocs, Victor actively promotes innovation and business acumen through engagements at schools, universities, and various competitions. His expertise spans CRISPR, genome editing, bioinformatics, personalized genome editing, CRISPR libraries, high throughput screening, NGS, synthetic biology, CRISPR therapeutics, epigenetics, genomics, entrepreneurship, and innovation.

    Victor has held diverse roles in prominent organizations such as VP of Strategy and Operations at Resolution Therapeutics, Strategic Advisor at Edilytics and CardiaTec Biosciences, Managing Director at INNOVIX, SVP at Owkin, VP of Gene Editing at Celixir, and more. His professional journey includes experiences with industry giants like GlaxoSmithKline and Procter & Gamble, highlighting his versatile expertise and commitment to advancing biotechnology.

    In addition to his professional pursuits, Victor has engaged in various roles within academic and extracurricular settings, showcasing his commitment to nurturing talent and fostering innovation. He continues to contribute actively to the field of biotechnology while advocating for the role of young talents in shaping the future of the industry.

    Highlights

    Feb 18 · Endpoints News
    Amgen, Ipsen vet moves up the ladder with Coherus's anti-PD-1 awaiting PDUFA; It takes a village to replace Frank Clyburn at Merck's Human Health business - Endpoints News
    Feb 18 · Endpoints News
    Amgen, Ipsen vet moves up the ladder with Coherus' anti-PD-1 ... - Endpoints News
    Amgen, Ipsen vet moves up the ladder with Coherus' anti-PD-1 ... - Endpoints News
    Victor Dillard
    Add to my network

    Location

    London, England, United Kingdom